𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts

✍ Scribed by Yamori, Takao ;Sato, Shigeo ;Chikazawa, Hirotaka ;Kadota, Toshihito

Book ID
108581381
Publisher
Wiley (Blackwell Publishing)
Year
1997
Tongue
English
Weight
366 KB
Volume
88
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Glucocorticoids interfere with therapeut
Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors
✍ Meihua Sui; Feng Chen; Zhi Chen; Weimin Fan πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 901 KB

## Abstract Paclitaxel is a widely used naturally occurring antineoplastic agent that has shown great promise in the treatment of a variety of human solid tumors, particularly for advanced breast and ovarian cancers. Recent studies in our laboratory discovered that glucocorticoids could selectively

Activity of paclitaxel liposome formulat
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts
✍ Amarnath Sharma; Eric Mayhew; Lois Bolcsak; C. Cavanaugh; P. Harmon; Andrew Jano πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 84 KB

Although the current clinical formulation of paclitaxel (Taxolt) is an important new anti-cancer agent, it has significant side effects, some of which are related to its formulation in Cremophor/ethanol. Paclitaxel is difficult to formulate for i.v. administration because of its poor aqueous solubil

Anti-tumor efficacy of naked siRNAs for
Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts
✍ Gunamani Sithanandam; Laura W. Fornwald; Janet R. Fields; Nicole L. Morris; Lucy πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 494 KB

## Abstract The use of siRNAs against specific molecular targets has potential for cancer therapy but has been thought to be limited by the need for formulation to improve cellular uptake. Lung adenocarcinoma cells are markedly suppressed in culture by siRNAs to the receptor ERBB3 or its downstream

Synergistic anti-tumor activity of isoch
Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells
✍ Yung-Luen Yu; Kuo-Jung Su; Cheng-Jueng Chen; Chyou-Wei Wei; Ching-Ju Lin; Giou-T πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 675 KB

## Abstract Drug resistance frequently develops in tumors during chemotherapy. Therefore, to improve the clinical outcome, more effective and tolerable combination treatment strategies are needed. Here, we show that isochaihulactone (K8) enhanced paclitaxel‐induced apoptotic death in human lung can